CL2009000247A1 -
Compounds derived from substituted aryl or heteroaryl sulfone; Pharmaceutical composition, and its use in the treatment of acute pain, chronic pain, epilepsy and sleep quality.
- Google Patents
Compounds derived from substituted aryl or heteroaryl sulfone; Pharmaceutical composition, and its use in the treatment of acute pain, chronic pain, epilepsy and sleep quality.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Neuromed PharmaceuticalfiledCriticalMerck & Co Inc
Priority to CL2009000247ApriorityCriticalpatent/CL2009000247A1/en
Publication of CL2009000247A1publicationCriticalpatent/CL2009000247A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos derivados de aril o heteroaril sulfona sustituido; composición farmacéutica, y su uso en el tratamiento del dolor agudo, dolor crónico, epilepsia y calidad del sueño.Compounds derived from substituted aryl or heteroaryl sulfone; pharmaceutical composition, and its use in the treatment of acute pain, chronic pain, epilepsy and sleep quality.
CL2009000247A2009-02-042009-02-04
Compounds derived from substituted aryl or heteroaryl sulfone; Pharmaceutical composition, and its use in the treatment of acute pain, chronic pain, epilepsy and sleep quality.
CL2009000247A1
(en)
Compounds derived from substituted aryl or heteroaryl sulfone; Pharmaceutical composition, and its use in the treatment of acute pain, chronic pain, epilepsy and sleep quality.
Compounds derived from substituted aryl or heteroaryl sulfone; Pharmaceutical composition, and its use in the treatment of acute pain, chronic pain, epilepsy and sleep quality.
Compounds derived from substituted aryl or heteroaryl sulfone; Pharmaceutical composition, and its use in the treatment of acute pain, chronic pain, epilepsy and sleep quality.
Compounds derived from imidazo [5,1-f] [1,2,4] triazines; pharmaceutical composition; and use in the treatment of cognitive impairment associated with schizophrenia.
Compounds derived from spiro- [1,3] -oxacins and spiro- [1,4] -oxacepins, inhibitors of bace1 and / or bace2; pharmaceutical composition; procedure to prepare them; and its use in the treatment and / or prophylaxis of Alzheimer's disease and diabetes.
Compounds derived from substituted phenylamino-benzene; Preparation method; pharmaceutical composition; farm kit; and use of said compounds in the treatment of cancer.
Compounds derived from substituted pyrrolidine-2-carboxamides, mdm2 antagonists; pharmaceutical composition; and its use in the treatment or prophylaxis of cancer.
COMPOUNDS DERIVED FROM PIRAZOLO-QUINAZOLINA SUBSTITUTED, MODULATORS OF THE ACTIVITY OF PROTEIN KINASES; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF CANCER.
Compounds derived from substituted pyridazinone; intermediate compound; pharmaceutical composition; pharmaceutical combination; and use in the treatment of schizophrenia, schizoaffective disorder, cognitive disorders or pain.
Compounds derived from 2- (methylamino) -n- (2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl) propanamide; pharmaceutical composition; and its use in the therapeutic or prophylactic treatment of cancer.
Pharmaceutical combinations comprising a component (a) corresponding to compounds derived from omega-carboxy-substituted-diphenylurea, (b) compounds derived from n- (2-arylamino) arylsulfonamide and (c) which are one or more additional pharmaceutical agents; and its use in the treatment of cancer
Compounds derived from benzyl sulfonamide, mogat-2 inhibitors; crystalline compound; pharmaceutical composition; and its use in the treatment of hypertriglyceridemia.
Compounds derived from 4-azetidinyl-1-heteroaryl-cyclohexanol; pharmaceutical composition; and use in the treatment of diseases such as epoc, atherosclerosis, rheumatoid arthritis, among others.